Next Article in Journal
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations
Previous Article in Journal
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
 
 
Article

Article Versions Notes

Curr. Oncol. 2023, 30(10), 8793-8804; https://doi.org/10.3390/curroncol30100634
Action Date Notes Link
article xml file uploaded 27 September 2023 03:13 CEST Original file -
article xml uploaded. 27 September 2023 03:13 CEST Update https://www.mdpi.com/1718-7729/30/10/634/xml
article pdf uploaded. 27 September 2023 03:13 CEST Version of Record https://www.mdpi.com/1718-7729/30/10/634/pdf
article supplementary file uploaded. 27 September 2023 03:13 CEST - https://www.mdpi.com/1718-7729/30/10/634#supplementary
article html file updated 27 September 2023 03:15 CEST Original file https://www.mdpi.com/1718-7729/30/10/634/html
Back to TopTop